相关实验视频
多中心伊斯拉迪尿动脉样硬化研究 (MIDAS) 的最终结论结果. 一个随机对照试验
N O Borhani1, M Mercuri, P A Borhani
1Department of Internal Medicine, School of Medicine, University of California at Davis, USA.
JAMA
|September 11, 1996
概括
这项研究发现,在伊斯拉迪平和甲之间,动脉内心-中枢厚度的进展没有差异. 然而,伊斯拉迪平与较高的血管事件发生率有关,需要进一步调查.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 医疗成像医学成像
背景情况:
- 高血压管理对于预防心血管疾病至关重要.
- 动脉内心-中枢厚度 (IMT) 是动脉样硬化的标志物.
- 对比不同抗高血压药物对动脉样硬化进展的影响是必不可少的.
研究的目的:
- 为了比较isradipine和hydrochlorothiazide之间动脉IMT进展的速度.
- 评估这些抗高血压药物治疗的患者血管事件的发生率.
主要方法:
- 随机,双盲,积极控制试验,涉及883名高血压患者.
- 定量B模式超声成像测量3年内平均最大IMT.
- 患者每天两次接受伊斯拉迪平或基亚胺.
主要成果:
- 在伊斯拉迪平和化胺之间没有观察到平均最大IMT进展率的显著差异 (P=.68).
- 与水甲治疗相比,伊斯拉迪平治疗与重大血管事件 (5.65% vs 3.17%) 和非重大血管事件/手术 (9.05% vs 5.22%) 的发病率较高 (P=0.07和P=0.02).
- 虽然这两种药物都降低了血压,但系统血压的差异无法解释isradipine增加的血管事件.
结论:
- 动脉IMT进展的替代终点在isradipine和hydrochlorothiazide之间没有区别.
- 在接受伊斯拉迪平治疗的患者中,血管事件的发生率增加是一个重大问题,需要进一步研究.
- 在这种患者群体中,甲酸可能是关于血管事件发生率的更安全选择.
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...